Glucose - The X factor for the survival of human fungal pathogens and disease progression in the host.
Autor: | Qadri H; Department of Bioresources, School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, J&K, India., Qureshi MF; Department of Biotechnology, Central University of Kashmir, Ganderbal, 191201, J&K, India., Mir MA; Department of Bioresources, School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, J&K, India. Electronic address: drmanzoor@kashmiruniversity.ac.in., Shah AH; Department of Bioresources, School of Biological Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, J&K, India. Electronic address: abdulhaseeb@kashmiruniversity.ac.in. |
---|---|
Jazyk: | angličtina |
Zdroj: | Microbiological research [Microbiol Res] 2021 Jun; Vol. 247, pp. 126725. Date of Electronic Publication: 2021 Feb 19. |
DOI: | 10.1016/j.micres.2021.126725 |
Abstrakt: | The incidence of human fungal infections is increasing due to the expansion of the immunocompromised patient population. The continuous use of different antifungal agents has eventually resulted in the establishment of resistant fungal species. The fungal pathogens unfold multiple resistance strategies to successfully tackle the effect of different antifungal agents. For the successful colonization and establishment of infection inside the host, the pathogenic fungi switch to the process of metabolic flexibility to regulate distinct nutrient uptake systems as well as to modulate their metabolism accordingly. Glucose the most favourable carbon source helps carry out the important survival and niche colonization processes. Adopting glucose as the center, this review has been put forward to provide an outline of the important processes like growth, the progression of infection, and the metabolism regulated by glucose, affecting the pathogenicity and virulence traits in the human pathogenic fungi. This could help in the identification of better treatment options and appropriate target-oriented antifungal drugs based on the glucose-regulated pathways and processes. In the article, we have also presented a summary of the novel studies and findings pointing to glucose-based potential therapeutic avenues to be explored to tackle the problem of globally increasing multidrug-resistant human fungal infections. (Copyright © 2021 Elsevier GmbH. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |